Table 1:
Analysis of days elapsed, age at diagnosis and BPDAI scores in study subjects.
| Days elapsed 2 | Age at diagnosis, years 3 | BPDAI 3, 4 | ||||
|---|---|---|---|---|---|---|
| Comparison 1 | Mean Ratio 5 95% CI |
p-value | Mean Ratio 95% CI |
p-value | Mean Ratio 95% CI |
p-value |
| ND+BP vs. BP CON | 0.515 0.496-0.534 |
<.0001 | 1.085 1.021-1.124 |
0.0085 | 1.059 0.707-1.587 |
0.7762 |
| PD+BP vs. BP CON | 0.333 0.312-0.355 |
<.0001 | 1.146 1.048-1.252 |
0.0030 | 0.935 0.543-1.610 |
0.8042 |
| DEM+BP vs. BP CON | 0.661 0.627-0.696 |
<.0001 | 1.143 1.046-1.249 |
0.0036 | 1.120 0.635-1.974 |
0.6911 |
| STR+ BP vs. BP CON | 0.624 0.587-0.663 |
<.0001 | 0.965 0.883-1.055 |
0.4297 | 1.200 0.582-2.476 |
0.6154 |
| PD+BP vs. STR+BP | 0.534 0.491-0.581 |
<.0001 | 1.187 1.056-1.335 |
0.0046 | 0.779 0.340-1.783 |
0.5474 |
| DEM+BP vs. STR+BP | 1.060 0.982-1.144 |
0.1337 | 1.184 1.053-1.331 |
0.0052 | 0.933 0.401-2.168 |
0.8693 |
| PD+BP vs. DEM+BP | 0.504 0.466-0.545 |
<.0001 | 1.003 0.892-1.128 |
0.9643 | 0.835 0.417-1.672 |
0.6045 |
1
Subjects included BP controls (BP CON), and BP patients with preceding neurologic disease (ND); Parkinson’s disease (PD+BP), dementia (DEM+BP), stroke (STR+BP)
2
calculated based on the interval between the onset of skin symptoms and BP diagnosis. N’s = 41 BP CON, 10 PD + BP, 8 DEM + BP, 6 STR + BP.
3
N’s = 77 BP CON, 11 PD + BP, 11 DEM + BP, 11 STR + BP.
4
Bullous Disease Area Index.
5
Mean ratio, 95% confidence interval (CI), and p-value are indicated for each comparison. A p-value <0.0071 was considered significant (bold font).